Anti-addiction groups push FDA to revoke approval of Zohydro
In a petition to the U.S. Food and Drug Administration, anti-addiction groups call the newly-approved drug Zohydro the next Oxycontin and they are warning if it is released to pharmacies as scheduled, it will also lead to more addiction and drug-related deaths. Wyatt Andrews reports.